Innate Pharma Ownership | Who Owns Innate Pharma?
Innate Pharma Ownership Summary
Innate Pharma is owned by 0.17% institutional investors, 1.70% insiders, and 98.13% retail investors. Jane street group is the largest institutional shareholder, holding 0.11% of IPHA shares. Telescope Biotech Fund A FIL is the top mutual fund, with 0.10% of its assets in Innate Pharma shares.
IPHA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Innate Pharma | 0.17% | 1.70% | 98.13% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Jane street group | 92.75K | 0.11% | $162.32K |
| Morgan stanley | 46.39K | 0.05% | $81.19K |
| Citadel advisors | 23.53K | 0.03% | $45.64K |
| Millennium management | 15.33K | 0.02% | $27.28K |
| Gamma investing | 1.07K | 0.00% | $1.88K |
| Ubs group | 947.00 | 0.00% | $1.66K |
| Rhumbline advisers | 470.00 | 0.00% | $916.00 |
| Optiver b.v. | 101.00 | 0.00% | $197.00 |
| Exchange traded concepts | - | - | - |
| Tower research capital llc (trc) | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Gamma investing | 1.07K | 0.00% | $1.88K |
| Tower research capital llc (trc) | - | - | - |
| Barclays | 1.00 | - | $2.00 |
| Optiver b.v. | 101.00 | - | $197.00 |
| Steward partners investment advisory | - | - | - |
| Jane street group | 92.75K | - | $162.32K |
| Rhumbline advisers | 470.00 | - | $916.00 |
| Millennium management | 15.33K | - | $27.28K |
| Ubs group | 947.00 | - | $1.66K |
| Citadel advisors | 23.53K | - | $45.64K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jane street group | 92.75K | - | 92.75K |
| Citadel advisors | 23.53K | - | 23.53K |
| Millennium management | 15.33K | - | 15.33K |
| Rhumbline advisers | 470.00 | - | - |
| Optiver b.v. | 101.00 | - | - |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Exchange traded concepts | - | - | -62.75K |
| Morgan stanley | 46.39K | - | -7.17K |
| Ubs group | 947.00 | - | -3.85K |
| Gamma investing | 1.07K | 0.00% | -1.21K |
| National bank of canada /fi/ | - | - | -450.00 |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Jane street group | 92.75K | - | 92.75K | $162.32K |
| Citadel advisors | 23.53K | - | 23.53K | $45.64K |
| Millennium management | 15.33K | - | 15.33K | $27.28K |
Sold Out
| Holder | Change |
|---|---|
| Tower research capital llc (trc) | -3.00 |
| Principal securities | -45.00 |
| Steward partners investment advisory | -200.00 |
| National bank of canada /fi/ | -450.00 |
| Exchange traded concepts | -62.75K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 7 | -22.22% | 146,382 | 79.35% | - | 1876.05% | 2 | -33.33% | 4 | 100.00% |
| Sep 30, 2025 | 9 | 28.57% | 81,617 | 271.04% | - | 12997.79% | 3 | 50.00% | 2 | -33.33% |
| Jun 30, 2025 | 9 | -10.00% | 99,838 | -36.89% | - | 323.31% | 4 | -20.00% | 3 | 200.00% |
| Mar 31, 2025 | 1 | -88.89% | 15,326 | -88.89% | - | 64.33% | 1 | -50.00% | - | -100.00% |
| Dec 31, 2024 | 5 | -37.50% | 78,982 | -66.82% | - | 111.34% | 2 | 100.00% | - | -100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Telescope Biotech Fund A FIL | 94.05K | 0.10% | 94.05K |
| Range Cancer Therapeutics ETF | 62.75K | 0.07% | - |
| ActivePassive International Equity ETF | 37.49K | 0.05% | 132.00 |
IPHA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools